$1.11
-0.005-0.45%
Últ. Act.: Oct 5, 7:51 PM
$1.10
-0.0218-1.95%
NeuroOne Medical Tech (NMTC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NeuroOne Medical Tech (NMTC) publicó su última previsión de octubre 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $10.5M - $10.5M para el período.
En comparación con la previsión anterior, NeuroOne Medical Tech elevado redujo su previsión de ingresos desde un rango anterior de $3.8M - $3.8M.
NeuroOne Medical Tech ha emitido 8 actualizaciones de orientación entre el enero 3, 2025 y el octubre 5, 2026. During this period, the company raised its outlook 1 time and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.23 | $-0.24 | $-0.24 |
| Actual | $-0.28 | $-0.25 | $-0.18 | $-0.24 |
| Surprise | -27.3% | -8.70% | +25.0% | 0.00% |
| Revenue | ||||
| Estimate | $2.5M | $2.6M | $2.7M | $2.5M |
| Actual | $2.0M | $2.4M | $2.9M | $2.7M |
| Surprise | -22.6% | -7.19% | +8.84% | +11.0% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.22 | $-0.17 |
| Revenue | ||
| Consensus | $2.8M | $3.3M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $-0.28 | $-0.22 | -27.3 % |
| Q2 | May 12, 2026 | $-0.25 | $-0.23 | -8.70 % |
| Q1 | Feb 17, 2026 | $-0.18 | $-0.24 | 25.0 % |
| Q4 | Dec 17, 2025 | $-0.24 | $-0.24 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $1.97M | $2.55M | -22.6 % |
| Q2 | May 12, 2026 | $2.39M | $2.58M | -7.19 % |
| Q1 | Feb 17, 2026 | $2.89M | $2.66M | 8.84 % |
| Q4 | Dec 17, 2025 | $2.74M | $2.47M | 11.0 % |